BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23063025)

  • 1. Comparison of insulin pump therapy (continuous subcutaneous insulin infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions.
    Corney SM; Dukatz T; Rosenblatt S; Harrison B; Murray R; Sakharova A; Balasubramaniam M
    J Diabetes Sci Technol; 2012 Sep; 6(5):1003-15. PubMed ID: 23063025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of continuous subcutaneous insulin infusion therapy in perioperative patients with diabetes mellitus.
    Ma D; Chen C; Lu Y; Ma J; Yin P; Xie J; Yang Y; Shao S; Liu Z; Zhou X; Yuan G; Yu X
    Diabetes Technol Ther; 2013 Dec; 15(12):1010-8. PubMed ID: 23971526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin pump patient characteristics and glucose control in the hospitalized setting.
    Kannan S; Satra A; Calogeras E; Lock P; Lansang MC
    J Diabetes Sci Technol; 2014 May; 8(3):473-8. PubMed ID: 24876608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAFETY AND EFFICACY OF A PERI-OPERATIVE PROTOCOL FOR PATIENTS WITH DIABETES TREATED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION WHO ARE ADMITTED FOR SAME-DAY SURGERY.
    Sobel SI; Augustine M; Donihi AC; Reider J; Forte P; Korytkowski M
    Endocr Pract; 2015 Nov; 21(11):1269-76. PubMed ID: 26280203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion reduces the risk of postoperative infection.
    Mou Y; Ma D; Zhang J; Tao J; He W; Li W; Mu Y; Yu X
    J Diabetes; 2020 May; 12(5):396-405. PubMed ID: 31697444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative glycemic management in insulin pump patients undergoing noncardiac surgery.
    Abdelmalak B; Ibrahim M; Yared JP; Modic MB; Nasr C
    Curr Pharm Des; 2012; 18(38):6204-14. PubMed ID: 22762462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
    Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
    Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
    Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
    Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy.
    Mackey PA; Thompson BM; Boyle ME; Apsey HA; Seifert KM; Schlinkert RT; Stearns JD; Cook CB
    J Diabetes Sci Technol; 2015 Jun; 9(6):1299-306. PubMed ID: 26092687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
    Raskin P; Bode BW; Marks JB; Hirsch IB; Weinstein RL; McGill JB; Peterson GE; Mudaliar SR; Reinhardt RR
    Diabetes Care; 2003 Sep; 26(9):2598-603. PubMed ID: 12941725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study.
    Drever E; Tomlinson G; Bai AD; Feig DS
    Diabet Med; 2016 Sep; 33(9):1253-9. PubMed ID: 26927202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery.
    Magaji V; Nayak S; Donihi AC; Willard L; Jampana S; Nivedita P; Eder R; Johnston J; Korytkowski MT
    Diabetes Technol Ther; 2012 Nov; 14(11):1013-7. PubMed ID: 23046399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Subcutaneous Insulin Infusions vs. Multiple Daily Injections of Insulin in Hospitalized Patients: Glycemic Trends in the First 24 Hours of Admission.
    Halstrom A; Moledina I; Peragallo-Dittko V; Ancona K; Islam S; Klek S; Rothberger G
    J Diabetes Sci Technol; 2022 May; 16(3):683-688. PubMed ID: 33563036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLYCEMIC OUTCOMES 3 YEARS AFTER IMPLEMENTATION OF A PERI-OPERATIVE GLYCEMIC CONTROL ALGORITHM IN AN ACADEMIC INSTITUTION.
    Arnold LM; Mahesri M; McDonnell ME; Alexanian SM
    Endocr Pract; 2017 Feb; 23(2):123-131. PubMed ID: 27819771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients.
    Lecomte P; Foubert L; Coddens J; Dewulf B; Nobels F; Casselman F; Cammu G
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):937-42. PubMed ID: 21640613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
    Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
    Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.